INT16393

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.08
First Reported 1991
Last Reported 2007
Negated 0
Speculated 0
Reported most in Abstract
Documents 4
Total Number 4
Disease Relevance 3.39
Pain Relevance 1.09

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Serpinf2) extracellular region (Serpinf2)
Anatomy Link Frequency
plasma 1
Serpinf2 (Mus musculus)
Pain Link Frequency Relevance Heat
cINOD 3 99.12 Very High Very High Very High
palliative 2 96.96 Very High Very High Very High
Angina 8 94.44 High High
COX2 1 60.40 Quite High
Inflammation 3 39.60 Quite Low
Disease Link Frequency Relevance Heat
Metastasis 4 99.82 Very High Very High Very High
Prostate Cancer 10 99.32 Very High Very High Very High
Benign Prostatic Hypertrophy 4 98.96 Very High Very High Very High
INFLAMMATION 6 98.92 Very High Very High Very High
Cyst 3 98.08 Very High Very High Very High
Coronary Artery Disease 2 96.64 Very High Very High Very High
Cv General 3 Under Development 8 94.44 High High
Myocardial Infarction 6 93.52 High High
Periventricular Leukomalacia 3 91.44 High High
Atherosclerosis 1 81.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We evaluated the effects of human recombinant tissue-plasminogen activator (hrt-PA), plasmin inhibitors (tranexamic acid, alpha2-antiplasmin, and aprotinin), and anti-inflammatory drugs (betamethasone, NS-398) in wild-type and t-PA(-/-) mice given high-dose or low-dose ibotenic acid.
Gene_expression (effects) of alpha2-antiplasmin associated with inflammation and cinod
1) Confidence 0.08 Published 2007 Journal Neuroscience Section Abstract Doc Link 17321054 Disease Relevance 0.62 Pain Relevance 0.27
Surprisingly, the levels of the other fibrinolysis marker, plasmin-alpha2-antiplasmin, showed no significant difference.
Gene_expression (levels) of plasmin-alpha2-antiplasmin
2) Confidence 0.02 Published 1997 Journal Eur J Clin Chem Clin Biochem Section Abstract Doc Link 9056745 Disease Relevance 0.65 Pain Relevance 0.08
In 49 patients with benign prostatic hyperplasia, 24 metastatic prostatic carcinoma patients all under palliative hormonal treatment, 17 untreated prostatic carcinoma patients without metastases and 14 untreated prostatic carcinoma patients with metastases, plasma levels of thrombin-antithrombin III complex, D-dimer and plasmin-alpha2-antiplasmin were determined.
Gene_expression (levels) of plasmin-alpha2-antiplasmin in plasma associated with benign prostatic hypertrophy, prostate cancer, metastasis and palliative
3) Confidence 0.02 Published 1997 Journal Eur J Clin Chem Clin Biochem Section Abstract Doc Link 9056745 Disease Relevance 0.74 Pain Relevance 0.10
In addition to Lp(a), serum plasminogen, alpha 2 antiplasmin, fibrinogen, and D-dimer (cross-linked fibrin degradation products) levels were measured.
Gene_expression (products) of alpha 2 antiplasmin
4) Confidence 0.01 Published 1991 Journal Am. J. Cardiol. Section Abstract Doc Link 1827942 Disease Relevance 1.39 Pain Relevance 0.64

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox